|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| (11) | Number of the document | 4019041 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21215762.2 |
| Date of filing the European patent application | 2013-07-12 | |
| (97) | Date of publication of the European application | 2022-06-29 |
| (45) | Date of publication and mention of the grant of the patent | 2022-12-28 |
| (46) | Date of publication of the claims translation | 2023-04-11 |
| (30) | Number | Date | Country code |
| 201261671482 P | 2012-07-13 | US | |
| 201361782982 P | 2013-03-14 | US |
| (72) |
JUNE, Carl H. , US
LEVINE, Bruce L. , US
KALOS, Michael D. , US
GRUPP, Stephan , US
|
| (73) |
The Trustees of the University of Pennsylvania ,
3600 Civic Center Boulevard, 9th Floor, Philadelphia, PA 19104,
US
The Children's Hospital of Philadelphia , 34th and Civic Center Boulevard, Philadelphia, PA 19104, US |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Toksiškumo, atsirandančio dėl CAR receptorių priešnavikinio aktyvumo, suvaldymas |
| TOXICITY MANAGEMENT FOR ANTI-TUMOR ACTIVITY OF CARS |
| Payment date | Validity (years) | Amount | |
| 2025-06-04 | 13 | 289.00 EUR |
| 2026-07-12 |